Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Immunology Drug market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Immunology Drug market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication
Segmented by End User/Segment
Hospitals
Clinics
Cancer Research Centers and Institutes
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Seattle Genetics
Sanofi Aventis LLC.
Pfizer
GlaxoSmithKline plc
Genentech
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Eisai Co.
Bayer AG
Autoimmune Inc.
Active Biotech
Abbott Laboratories
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Immunology Drug Market Status and Forecast (2016-2027) 1.3.2 Global Immunology Drug Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Immunology Drug Supply by Company 2.1 Global Immunology Drug Sales Volume by Company 2.2 Global Immunology Drug Sales Value by Company 2.3 Global Immunology Drug Price by Company 2.4 Immunology Drug Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Immunology Drug Market Status by Category 3.1 Immunology Drug Category Introduction 3.1.1 Monoclonal Antibodies (mAb) 3.1.2 Antibody Drug Conjugates 3.1.3 Interferon and Cytokine therapies 3.1.4 Immunosuppressive medication 3.2 Global Immunology Drug Market by Category 3.2.1 Global Immunology Drug Sales Volume by Category (2016-2021) 3.2.2 Global Immunology Drug Sales Value by Category (2016-2021) 3.2.3 Global Immunology Drug Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Immunology Drug Market Status by End User/Segment 4.1 Immunology Drug Segment by End User/Segment 4.1.1 Hospitals 4.1.2 Clinics 4.1.3 Cancer Research Centers and Institutes 4.2 Global Immunology Drug Market by End User/Segment 4.2.1 Global Immunology Drug Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Immunology Drug Sales Value by End User/Segment (2016-2021) 4.2.3 Global Immunology Drug Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Immunology Drug Market Status by Region 5.1 Global Immunology Drug Market by Region 5.1.1 Global Immunology Drug Sales Volume by Region 5.1.2 Global Immunology Drug Sales Value by Region 5.2 North America Immunology Drug Market Status 5.3 Europe Immunology Drug Market Status 5.4 Asia Pacific Immunology Drug Market Status 5.5 Central & South America Immunology Drug Market Status 5.6 Middle East & Africa Immunology Drug Market Status6 North America Immunology Drug Market Status 6.1 North America Immunology Drug Market by Country 6.1.1 North America Immunology Drug Sales Volume by Country (2016-2021) 6.1.2 North America Immunology Drug Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Immunology Drug Market Status 7.1 Europe Immunology Drug Market by Country 7.1.1 Europe Immunology Drug Sales Volume by Country (2016-2021) 7.1.2 Europe Immunology Drug Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Immunology Drug Market Status 8.1 Asia Pacific Immunology Drug Market by Country 8.1.1 Asia Pacific Immunology Drug Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Immunology Drug Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Immunology Drug Market Status 9.1 Central & South America Immunology Drug Market by Country 9.1.1 Central & South America Immunology Drug Sales Volume by Country (2016-2021) 9.1.2 Central & South America Immunology Drug Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Immunology Drug Market Status 10.1 Middle East & Africa Immunology Drug Market by Country 10.1.1 Middle East & Africa Immunology Drug Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Immunology Drug Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Immunology Drug Manufacturing Cost Analysis 11.5 Immunology Drug Sales Channel and Distributors Analysis 11.5.1 Immunology Drug Sales Channel 11.5.2 Immunology Drug Distributors 11.6 Immunology Drug Downstream Major Buyers12 Global Immunology Drug Market Forecast by Category and by End User/Segment 12.1 Global Immunology Drug Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Immunology Drug Forecast by Category 12.2.1 Global Immunology Drug Sales Volume Forecast by Category 12.2.2 Global Immunology Drug Sales Value Forecast by Category 12.2.3 Global Immunology Drug Price Forecast by Category 12.3 Global Immunology Drug Forecast by End User/Segment 12.3.1 Global Immunology Drug Sales Volume Forecast by End User/Segment 12.3.2 Global Immunology Drug Sales Value Forecast by End User/Segment 12.3.3 Global Immunology Drug Price Forecast by End User/Segment13 Global Immunology Drug Market Forecast by Region/Country 13.1 Global Immunology Drug Market Forecast by Region (2022-2027) 13.1.1 Global Immunology Drug Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Immunology Drug Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Seattle Genetics 14.1.1 Company Information 14.1.2 Immunology Drug Product Introduction 14.1.3 Seattle Genetics Immunology Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Sanofi Aventis LLC. 14.2.1 Company Information 14.2.2 Immunology Drug Product Introduction 14.2.3 Sanofi Aventis LLC. Immunology Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Pfizer 14.3.1 Company Information 14.3.2 Immunology Drug Product Introduction 14.3.3 Pfizer Immunology Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 GlaxoSmithKline plc 14.4.1 Company Information 14.4.2 Immunology Drug Product Introduction 14.4.3 GlaxoSmithKline plc Immunology Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Genentech 14.5.1 Company Information 14.5.2 Immunology Drug Product Introduction 14.5.3 Genentech Immunology Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 F. Hoffmann-La Roche Ltd. 14.6.1 Company Information 14.6.2 Immunology Drug Product Introduction 14.6.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Eli Lilly and Company 14.7.1 Company Information 14.7.2 Immunology Drug Product Introduction 14.7.3 Eli Lilly and Company Immunology Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Eisai Co. 14.8.1 Company Information 14.8.2 Immunology Drug Product Introduction 14.8.3 Eisai Co. Immunology Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Bayer AG 14.9.1 Company Information 14.9.2 Immunology Drug Product Introduction 14.9.3 Bayer AG Immunology Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Autoimmune Inc. 14.10.1 Company Information 14.10.2 Immunology Drug Product Introduction 14.10.3 Autoimmune Inc. Immunology Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 Active Biotech 14.12 Abbott Laboratories15 Conclusion16 Methodology